RETAIL NEWS

LONDON — Despite the World Health Organization citing immunization as one of the most powerful and cost-effective interventions in public health, a new survey conducted by Ipsos MORI and sponsored by GSK Vaccines in Brazil, Germany, India, Italy and the United States found that 68% of adults are not up-to-date with the vaccines recommended for them.

Almost three in 10 adults report not having had any of the vaccines potentially relevant to them within the past five years.

PHOENIX — FastMed Urgent Care on Thursday named Web Golinkin as its new CEO. In this capacity, he will lead FastMed's large and growing portfolio of walk-in urgent care health clinics located across Arizona, Texas and North Carolina.

WOONSOCKET, R.I. — CVS Health is marking American Diabetes Month by emphasizing efforts patients can undertake to manage their conditions, as well as the services the company offers to make diabetes management easier.

The company said patients with diabetes should manage their diet and engage in a healthy lifestyle — including at least 30 minutes of exercise daily — in an effort to manage their blood glucose, blood pressure and cholesterol. CVS pharmacists also can offer information and product suggestions to aid lifestyle management, CVS Health said.

CHICAGO —  IRI announced Tuesday that it will begin providing supply chain services to Albertsons, the second largest grocery chain in the United States, in addition to being its preferred partner for point-of-sale data, consumer panel insights and strategic growth initiatives to support joint business collaboration.

ZAANDAM, the Netherlands — Ahold Delhaize delivered strong performance in the U.S. on the strength of strong volume growth across its Food Lion banner, supported by the rollout of that banner's "Easy, Fresh & Affordable" strategy, whereas Stop & Shop New England benefited from a strong summer holiday season.

CINCINNATI — Kroger on Wednesday announced its cloud computing portfolio is expanding with Google Cloud Platform.

SAN FRANCISCO — McKesson on Monday announced that it has signed a definitive agreement to purchase RxCrossroads from CVS Health in a deal valued at $735 million. The acquisition is expected to close in the fourth quarter of fiscal 2018, subject to customary closing conditions, including necessary regulatory clearances.